about
Analysis of patient outcomes following proton radiation therapy for retinoblastoma.A prospective study of quality of life in breast cancer patients undergoing radiation therapy.Feasibility of automated 3-dimensional magnetic resonance imaging pancreas segmentation.Modeling of chronic radiation-induced cystitis in mice.Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy.Effects of vertebral-body-sparing proton craniospinal irradiation on the spine of young pediatric patients with medulloblastoma.Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas.Use of acupuncture to alleviate side effects in radiation oncology: Current evidence and future directions.Radiation-induced erectile dysfunction: Recent advances and future directions.18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanomaThe relationship between cardiac radiation dose and mediastinal lymph node involvement in stage III non-small cell lung cancer patients.Functional image guided radiation therapy planning in volumetric modulated arc therapy for patients with malignant pleural mesothelioma.Preserving the legacy of reirradiation: A narrative review of historical publications.Adjuvant radiation for salivary gland malignancies is associated with improved survival: A National Cancer Database analysis.Independent test of a model to predict severe acute esophagitis.Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters.The big data effort in radiation oncology: Data mining or data farming?Satisfaction of breast cancer patients regarding surgery and radiation therapy: A survey in Japan.Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging.FGF18 signaling in the hair cycle resting phase determines radioresistance of hair follicles by arresting hair cycling.A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases.Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility studyCharacterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center expeSevere radiation-induced leukoencephalopathy: Case report and literature review.Neutron radiation therapy for advanced thyroid cancers.Oncoplastic breast surgery in the setting of breast-conserving therapy: A systematic review.Cryptic Nocardia nova brain abscess postradiation treatment and neurosurgery in a patient with small cell lung cancer: A case report and review of the literature.Hypofractionated image guided radiation therapy followed by prostate seed implant boost for men with newly diagnosed intermediate and high risk adenocarcinoma of the prostate: Preliminary results of a phase 2 prospective study.The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.Lessons learned from reirradiation of recurrent skull base meningioma: A case report and review of the literature.Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer.Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer.ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer.Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma.Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center.Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy.Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial.
P1433
Q33782262-D8EB12D6-ED3E-407C-ABCB-010A1CF1ABB6Q37108977-323D8A9B-5ED6-412C-A8B6-FC7CA48B03B1Q37420006-A0430D6F-853B-460C-8EBE-74E326F24FDDQ37646108-ED0D259D-B6CD-436B-92FF-57A2710FBCC8Q38399664-56E6072E-A917-4166-AC14-94AE3C48378CQ38629152-8F2FEDA5-0A3B-4941-B639-A163EA694D8FQ38652295-ECFFDD6A-BB34-4012-82F5-BA08CB3B6079Q38652298-FE1E98BF-F8AF-40ED-A404-0F1C0DDF71E5Q38652302-D26B7450-AEFD-43F4-A03E-E6A588D1C618Q38652305-98C00B28-089E-42D5-A3E9-F907239F70CBQ38663172-4D782960-A227-47E6-BE1B-BCF78034463EQ38663176-53E1C1DB-910E-45E8-AB87-4AC02B82EE95Q38663179-ABE1B28C-5A16-422D-88B9-D51FC2B1904CQ38663182-B0775BED-99F0-462B-AD76-6036086B462DQ38663185-3AA9D989-D923-4BC5-A5AB-1FCE2CF3FE13Q38663190-6E35C9E9-0B7D-4D8D-8356-40681EFDB661Q38663192-8C7A80C6-9CF6-4857-8A7E-F5B0E396B5BFQ38663195-78D63C09-F22E-44C4-8CA6-07D65A6EEBF5Q38663197-B95ACD03-E794-4AEF-B32D-19B90E38F624Q38663202-9EF8A249-E5C8-4162-9D20-2A7B7E80456BQ38696429-8EA18B0C-410D-4F09-BCF1-8BC532176E4CQ38888199-F6D812EE-825D-4A6E-B20B-D7749F94A277Q38908069-B1C13B1D-E85E-48B3-8EE2-279BC3558A87Q39152339-1287C9E2-E0FB-43A1-AB1F-4D0D053EA641Q39456129-37FFF2B0-4265-4068-8EE4-052E5719C1C8Q39456136-D844737F-4102-491F-B7B8-A78BCF97548AQ39456147-011CF59C-46C9-47A0-98CD-B10DE7896E11Q39456158-DD328870-85E3-47DD-A72A-A052C6602779Q39456165-73C1A720-4817-4DD7-BBB0-686DAC693482Q39456177-62176990-D91B-4FA4-9557-BF3C10367C22Q39456183-8FC53A32-44FA-4D90-90AB-F25AE9B2D71BQ39456189-AE873573-84BB-44D8-8EAF-7ACE1F76D691Q39456195-8869A7E4-3C09-49D5-A259-4DEB2F7C0678Q39456200-7DE5D771-3EBA-41D4-B4E3-840F2D34A69BQ39456208-0F7380A5-05C8-4C6F-87CE-F774A1963AA5Q39456225-C9E94E35-687C-4B75-8C23-A95EA9CA480BQ40109681-73494DD0-D73F-4CD3-943C-B564737DD3CFQ40109688-4B04E5E4-AFD3-4969-B9AF-977BBDC5C6AEQ40121235-57D9FA28-26E0-4E56-A8AE-967CFDBEFFB6Q40121242-156EB072-AE44-41C6-A613-734086000C9B
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Advances in radiation oncology
@ast
Advances in radiation oncology
@en
Advances in radiation oncology
@es
Advances in radiation oncology
@nl
type
label
Advances in radiation oncology
@ast
Advances in radiation oncology
@en
Advances in radiation oncology
@es
Advances in radiation oncology
@nl
altLabel
Adv Radiat Oncol
@en
Advances in Radiation Oncology
@en
prefLabel
Advances in radiation oncology
@ast
Advances in radiation oncology
@en
Advances in radiation oncology
@es
Advances in radiation oncology
@nl
P31
P1055
P1156
21100465104
P123
P1476
Advances in radiation oncology
@en
P236
P5115
P5963
advances-in-radiation-oncology